(Press-News.org) Just over 200,000 Americans suffer from systemic lupus erythematosus, or SLE, a condition in which the body's immune system mistakenly attacks its own healthy tissues, especially joints and skin, a new study shows.
Led by a researcher at NYU Grossman School of the Medicine, the study provides the first national estimate of how widespread the autoimmune disease is since the U.S. Centers for Disease Control and Prevention (CDC) set up a half dozen state registries to track the illness more than a decade ago. SLE affects mostly women, can be fatal, and often involves debilitating flare-ups of fatigue and pain that keep nearly half of adult patients from working.
Importantly, the researcher says the report, publishing in the journal Arthritis and Rheumatology online Jan. 21, comes statistically close to officially reclassifying the illness as a rare disease, which disproportionately affects mostly American Indian/Alaskan Native, Black, and Hispanic females. The U.S. Rare Diseases Act of 2002 classifies such conditions as those affecting 200,000 or fewer Americans.
Until now, researchers had relied on disease estimates that were larger but unverified.
"Our study potentially redefines systemic lupus erythematosus as a rare disease in the United States and lays the groundwork for where we need to focus our efforts to reduce the burden of this disease on Americans," says study lead investigator and rheumatologist Peter Izmirly, MD. Izmirly is an associate professor in the Department of Medicine at NYU Langone Health.
Rare-disease classification could, the investigator says, significantly change efforts to study and treat SLE by decreasing the number of study participants needed for testing new treatments and shaping the design of clinical trials needed before seeking regulatory approval. He also says the team's findings could help plan which neighborhoods or population groups need extra medical resources, including specialty rheumatology clinics, to combat SLE.
Current treatments for lupus, he notes, include steroids or other anti-inflammatory and immunosuppressing medications, especially newer biologic drugs, made from living cells, to prevent patients' immune system's attack on their tissues.
For the study, researchers at NYU Langone and elsewhere analyzed records for 5,417 adults and children diagnosed with SLE since 2002 at all of the state registries for the disease, as well as the Indian Native Health Service. They then calculated the number of people with SLE for every gender and ethnic group and applied those demographic numbers to national population statistics from the 2018 U.S. Census. They concluded that among every 100,000 people nationwide, 72.8 had SLE, for a total of 204,295 out of a population of 330 million.
Their calculations also found that nine times more women than men have SLE, the dominant form of lupus. SLE rates were highest among Native American/Alaskan Native females, at 270.6 per 100,000. Black females ranked next, at 230.9 per 100,000, followed by Hispanic females, at 120.7 per 100,000. Similar disparities were seen among males with SLE, with American Indians/Alaskan Natives having the highest number, at 53.8 per 100,000, and Black males next, at 26.7 per 100,000.
INFORMATION:
Funding support for the study was provided by New York City's Department of Health and Mental Hygiene. Additional support was provided by the CDC; state lupus registries in Georgia, Michigan, California, and New York; the Indian Health Service, and National Institutes of Health grant UL1 TR002240.
Izmirly has served on an advisory board sponsored by GlaxoSmithKline, a manufacturer of drugs used to treat SLE. These arrangements are being managed in accordance with the policies and practices of NYU Langone.
Besides Izmirly, other researchers involved in the studies are Hilary Parton, MPH, at New York City's Department of Health and Mental Hygiene; Lu Wang, PhD; W. Joseph McCune, MD; and senior investigator Emily Somers, PhD, ScM, at the University of Michigan in Ann Arbor; S. Sam Lim, MD, MPH, and Christina Drenkard, MD, PhD, at Emory University in Atlanta; Elizabeth Ferucci, MD, MPH, at the Alaska Native Tribal Health Consortium in Anchorage; Maria Dall'Era, MD, at the University of California at San Francisco; Caroline Gordon, MD, at the University of Birmingham in the United Kingdom; and Charles Helmick, MD, at the CDC in Atlanta.
Media Inquiries:
David March
212-404-3528
mailto:david.march@nyulangone.org
PHILADELPHIA--Patients with inactive cancer and not currently undergoing treatments also face a significantly higher risk of severe illness from COVID-19, a new study from Penn Medicine published online today in JNCI Cancer Spectrum shows. Past reports have established an increased risk of severe disease and death for sick or hospitalized cancer patients with COVID-19 compared to patients without cancer, but less is known about patients in the general population.
The findings underscore the importance of COVID-19 mitigation, like social distancing and mask wearing, and vaccinations for all patients, not just those recently diagnosed or with active disease.
"Patients who have cancer need to be careful ...
New research has shown that people are more likely to follow Covid-19 restrictions based on what their friends do, rather than their own principles.
Research led by the University of Nottingham carried out in partnership with experts in collective behaviour from British, French, German and American universities shows how social influence affects people's adherance to government restrictions. The researchers found that the best predictor of people's compliance to the rules was how much their close circle complied with the rules, which had an even stronger effect than people's own approval of the rules.
The research published in British Journal of Psychology highlights a blindspot in policy responses ...
The US prevalence of the autoimmune disease lupus is 72.8 cases per 100,000 individuals, according to an analysis of population-based registries. The analysis, which is published in END ...
Where people die can affect the quality of their deaths and the end-of-life care that they receive. A study published in the END ...
Pharmacists play an important role in managing medication-based therapies for older community-dwelling patients, according to a study published in the END ...
Prostate cancer is one of the most common cancers among men. Patients are determined to have prostate cancer primarily based on *PSA, a cancer factor in blood. However, as diagnostic accuracy is as low as 30%, a considerable number of patients undergo additional invasive biopsy and thus suffer from resultant side effects, such as bleeding and pains.
*Prostate-Specific Antigen (PSA): a prostate-specific antigen (a cancer factor) used as an index for the screening of prostate cancer.
The Korea Institute of Science and Technology (KIST) announced that the collaborative research team led by Dr. Kwan Hyi Lee from the Biomaterials Research Center and Professor In Gab Jeong from Asan Medical Center developed a technique ...
Pathogenic bacteria in humans are developing resistance to antibiotics much faster than expected. Now, computational research at Chalmers University of Technology, Sweden, shows that one reason could be significant genetic transfer between bacteria in our ecosystems and to humans. This work has also led to new tools for resistance researchers.
According to the World Health Organisation, antibiotic resistance is one of the greatest threats to global health, food safety and development. It already causes over 33,000 deaths a year in Europe alone.
Completely ...
Since 1997 (Reno vs. American Civil Liberties Union), the Supreme Court has used the metaphor of the free market of ideas to define the Internet, thus addressing the regulation of the net as a matter of freedom of speech. In law, metaphors have a constitutive value and, once established, affect the debate and the decisions of the Courts for a long time. In the paper 'Judicial Frames and Fundamental Right in Cyberspace', published in the American Journal of Comparative Law, Oreste Pollicino (Bocconi University) and Alessandro Morelli (Università Magna Graecia, Catanzaro) apply to judicial reasoning reflections on metaphors and go so far as to criticize, on the one hand, the US Supreme Court's orientations on (non-)regulation of the Internet and, on the other, to invoke changes ...
In the first systematic large-scale evaluation of the UK National Early Warning Risk Score (NEWS) 2 as a scoring system for predicting severe COVID-19 outcomes in patients, researchers at King's College London have found poor-to-moderate accuracy for identifying patients at risk of being transferred to intensive care units (ICUs) or dying after 14 days of hospitalisation. Accuracy of predictions in short term (three days) showed moderate success.
For people who are hospitalised with severe COVID-19, it is vital to quickly identify which patients may deteriorate and require transfer to an intensive care unit (ICU) for organ support or may die. NEWS2 is an ...
Researchers from the University of Cambridge have discovered a fossil of the earliest starfish-like animal, which helps us understand the origins of the nimble-armed creature.
The prototype starfish, which has features in common with both sea lilies and modern-day starfish, is a missing link for scientists trying to piece together its early evolutionary history.
The exceptionally preserved fossil, named Cantabrigiaster fezouataensis, was discovered in Morroco's Anti-Atlas mountain range. Its intricate design - with feathery arms akin to a lacework - has been frozen in time for roughly 480 million years.
The new species is unusual because it doesn't have many of the key features of its contemporary relatives, lacking roughly 60% of ...
